{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:23:26Z","timestamp":1790015006151,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.06.036","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:40:31Z","timestamp":1782517231000},"page":"5319-5332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis"],"prefix":"10.1016","volume":"34","author":[{"given":"Juhong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saehong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munjeong","family":"Yum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2602-7186","authenticated-orcid":false,"given":"Yun-Ju","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-1043","authenticated-orcid":false,"given":"Dong Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.06.036_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry Eye Disease: An Immune-Mediated Ocular Surface Disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","article-title":"Inflammation and its role in age-related macular degeneration","volume":"73","author":"Kauppinen","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2026.06.036_bib3","doi-asserted-by":"crossref","first-page":"8387","DOI":"10.3390\/ijms22168387","article-title":"Retinal Pigment Epithelium Expressed Toll-like Receptors and Their Potential Role in Age-Related Macular Degeneration","volume":"22","author":"Klettner","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.ymthe.2026.06.036_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: clinical features and potential therapeutic approaches","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.06.036_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40123-017-0086-6","article-title":"A Review of Current and Future Management of Geographic Atrophy","volume":"6","author":"Sacconi","year":"2017","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.036_bib6","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2019.09.024","article-title":"Age-Related Macular Degeneration Preferred Practice Pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.06.036_bib7","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.oret.2019.11.004","article-title":"Non-responders to ranibizumab Anti-VEGF treatment are actually short-term responders: A prospective SD-OCT study","volume":"4","author":"Bontzos","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.ymthe.2026.06.036_bib8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41433-021-01562-6","article-title":"Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series","volume":"36","author":"Garweg","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.ymthe.2026.06.036_bib9","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/IAE.0000000000002779","article-title":"Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration","volume":"40","author":"Teo","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2026.06.036_bib10","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2026.06.036_bib11","first-page":"269","article-title":"Quintessence of currently approved and upcoming treatments for dry eye disease","volume":"263","author":"Patil","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1159\/000525696","article-title":"Prevalence and Incidence of Dry Eye Disease in Asia: A Systematic Review and Meta-Analysis","volume":"65","author":"Cai","year":"2022","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ymthe.2026.06.036_bib13","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2147\/OPTH.S465143","article-title":"Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies","volume":"18","author":"Gupta","year":"2024","journal-title":"OPTH"},{"key":"10.1016\/j.ymthe.2026.06.036_bib14","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1167\/iovs.17-23397","article-title":"MyD88 Deficiency Protects Against Dry Eye\u2013Induced Damage","volume":"59","author":"Reins","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.06.036_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12703\/P6-97","article-title":"MyD88: a central player in innate immune signaling","volume":"6","author":"Deguine","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.ymthe.2026.06.036_bib16","article-title":"BMSC reduces ROS and inflammation levels by inhibiting TLR4\/MYD88\/NF-\u03baB signaling axis to alleviate dry eye","author":"Zhao","year":"2023","journal-title":"Res. Square"},{"key":"10.1016\/j.ymthe.2026.06.036_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.4450","article-title":"cGAS drives noncanonical-inflammasome activation in age-related macular degeneration","volume":"24","author":"Kerur","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.06.036_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature09830","article-title":"DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration","volume":"471","author":"Kaneko","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.036_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","article-title":"DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88","volume":"149","author":"Tarallo","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.06.036_bib20","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1167\/iovs.09-4464","article-title":"Choroidal Neovascularization Enhanced by Chlamydia pneumoniae via Toll-like Receptor 2 in the Retinal Pigment Epithelium","volume":"51","author":"Fujimoto","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.06.036_bib21","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.3892\/mmr.2016.4890","article-title":"TLR4 inhibitor attenuates amyloid-\u03b2-induced angiogenic and inflammatory factors in ARPE-19 cells: Implications for age-related macular degeneration","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2026.06.036_bib22","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.ajpath.2017.06.015","article-title":"A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration","volume":"187","author":"Feng","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Sig Transduct Target. Ther."},{"key":"10.1016\/j.ymthe.2026.06.036_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/ph13100294","article-title":"Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside","volume":"13","author":"Sajid","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ymthe.2026.06.036_bib25","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1093\/emboj\/20.23.6877","article-title":"Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate","volume":"20","author":"Elbashir","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2026.06.036_bib26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/mt.2008.298","article-title":"Asymmetric Shorter-duplex siRNA Structures Trigger Efficient Gene Silencing With Reduced Nonspecific Effects","volume":"17","author":"Chang","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.036_bib27","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.jid.2016.06.626","article-title":"Development of Cell-Penetrating Asymmetric Interfering RNA Targeting Connective Tissue Growth Factor","volume":"136","author":"Hwang","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/acs.molpharmaceut.9b00942","article-title":"L-Type Calcium Channel Blocker Enhances Cellular Delivery and Gene Silencing Potency of Cell-Penetrating Asymmetric siRNAs","volume":"17","author":"Choe","year":"2020","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.ymthe.2026.06.036_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/acs.molpharmaceut.2c00510","article-title":"Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia","volume":"20","author":"Moon","year":"2023","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.ymthe.2026.06.036_bib30","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.4103\/1673-5374.147927","article-title":"Sodium iodate induced retinal degeneration: new insights from an old model","volume":"9","author":"Hinton","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymthe.2026.06.036_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.31083\/j.fbl2911380","article-title":"Sodium Iodate: Rapid and Clinically Relevant Model of AMD","volume":"29","author":"Geathers","year":"2024","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ymthe.2026.06.036_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/eye.2017.241","article-title":"Inflammasomes, the eye and anti-inflammasome therapy","volume":"32","author":"Yerramothu","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.ymthe.2026.06.036_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/jcm4010172","article-title":"NLRP3 Inflammasome and Pathobiology in AMD","volume":"4","author":"Celkova","year":"2015","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2026.06.036_bib34","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/ATVBAHA.118.311916","article-title":"Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich\u2013Containing Family, Pyrin Domain\u2013Containing-3) Inflammasome in Cardiovascular Disorders","volume":"38","author":"Wang","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib35","first-page":"1343","article-title":"The role of Toll-like receptors in retinal ischemic diseases","volume":"9","author":"Xu","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.110111","article-title":"The impact of NF-\u03baB on inflammatory and angiogenic processes in age-related macular degeneration","volume":"248","author":"Almalki","year":"2024","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.06.036_bib37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10792-014-9969-x","article-title":"The role and treatment of inflammation in dry eye disease","volume":"34","author":"Yagci","year":"2014","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.3RI0615-239R","article-title":"Parainflammation, chronic inflammation, and age-related macular degeneration","volume":"98","author":"Chen","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/jop.2024.0103","article-title":"Inflammation in Dry Eye Disease-Pathogenesis, Preclinical Animal Models, and Treatments","volume":"40","author":"Bhujbal","year":"2024","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.036_bib40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ymthe.2017.12.021","article-title":"Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates","volume":"26","author":"Foster","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.036_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111514","article-title":"Retinal degeneration rat model: A study on the structural and functional changes in the retina following injection of sodium iodate","volume":"196","author":"Koh","year":"2019","journal-title":"J. Photochem. Photobiol. B: Biol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109728","article-title":"Regulated cell death pathways in the sodium iodate model: Insights and implications for AMD","volume":"238","author":"Upadhyay","year":"2024","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.06.036_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2016.54","article-title":"Retinal pigment epithelial cell necroptosis in response to sodium iodate","volume":"2","author":"Hanus","year":"2016","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ymthe.2026.06.036_bib44","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1167\/iovs.13-12500","article-title":"TLR-Independent and P2X7-Dependent Signaling Mediate Alu RNA-Induced NLRP3 Inflammasome Activation in Geographic Atrophy","volume":"54","author":"Kerur","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.06.036_bib45","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0608100104","article-title":"NF-\u03baB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1","volume":"104","author":"Miggin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.036_bib46","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/s41598-020-58849-z","article-title":"Caspase-1-dependent inflammasomes mediate photoreceptor cell death in photo-oxidative damage-induced retinal degeneration","volume":"10","author":"Wooff","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.06.036_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.06.036_bib48","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4172\/2155-9570.1000562","article-title":"miR-146a is Upregulated During Retinal Pigment Epithelium (RPE)\/Choroid Aging in Mice and Represses IL-6 and VEGF-A Expression in RPE Cells","volume":"7","author":"Hao","year":"2016","journal-title":"J. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9490642","article-title":"Tangeretin Inhibition of High-Glucose-Induced IL-1\u03b2, IL-6, TGF-\u03b21, and VEGF Expression in Human RPE Cells","volume":"2020","author":"Qin","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ymthe.2026.06.036_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.61.6.4","article-title":"Inhibiting NF-\u03baB Signaling Activation Reduces Retinal Neovascularization by Promoting a Polarization Shift in Macrophages","volume":"61","author":"Sui","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.06.036_bib51","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1021\/acs.jmedchem.0c00884","article-title":"Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR\/IL-1R Signaling","volume":"63","author":"Chen","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2026.06.036_bib52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88\u2013IRAK4\u2013IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.036_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.str.2020.01.003","article-title":"MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling","volume":"28","author":"Moncrieffe","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.ymthe.2026.06.036_bib54","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202012071","article-title":"MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling","volume":"220","author":"Deliz-Aguirre","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.06.036_bib55","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.str.2020.05.006","article-title":"Cobbling Together the Myddosome","volume":"28","author":"Snyder","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.ymthe.2026.06.036_bib56","article-title":"Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration","volume":"2","author":"Lin","year":"2022","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.ymthe.2026.06.036_bib57","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3390\/jcm10132890","article-title":"Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results","volume":"10","author":"Lin","year":"2021","journal-title":"JCM"},{"key":"10.1016\/j.ymthe.2026.06.036_bib58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.06.036_bib59","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2026.06.036_bib60","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1097\/MS9.0000000000001466","article-title":"Advancements in the treatment of geographic atrophy: focus on pegcetacoplan in age-related macular degeneration","volume":"85","author":"Nadeem","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ymthe.2026.06.036_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132643","article-title":"Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2026.06.036_bib62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","article-title":"Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti\u2013Vascular Endothelial Growth Factor Antibody Fragment","volume":"120","author":"Krzystolik","year":"2002","journal-title":"Arch. Ophthalmol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:23:49Z","timestamp":1788362629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626005149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626005149"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.036","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}